Immunovia AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 3, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	137	153	93	80	595	1,697
Market Cap Growth	17.67%	64.79%	15.47%	-86.52%	-64.93%	-37.08%
Enterprise Value	81	146	40	-0	476	1,393
Last Close Price	0.20	0.23	0.42	1.38	18.98	54.12
PS Ratio	151.13	222.91	99.53	50.95	519.84	2011.10
PB Ratio	2.95	2.36	7.96	1.20	2.44	3.91
P/TBV Ratio	3.43	2.63	9.55	1.25	2.70	4.15
EV/Sales Ratio	89.36	213.86	42.92	-	415.93	1650.16
Debt / Equity Ratio	-	0.01	0.06	0.15	0.15	0.08
Net Debt / Equity Ratio	-1.21	-1.18	-2.12	-0.99	-0.28	-0.59
Net Debt / EBITDA Ratio	0.69	0.95	0.23	0.40	0.37	1.58
Net Debt / FCF Ratio	0.75	0.98	0.26	0.45	0.39	1.63
Asset Turnover	0.02	0.01	0.01	0.01	0.00	0.00
Inventory Turnover	-	-	-	-	2.02	-
Quick Ratio	3.04	5.02	1.75	2.62	4.55	8.91
Current Ratio	3.05	5.12	1.82	2.69	4.80	9.07
Return on Equity (ROE)	-281.30%	-382.06%	-194.66%	-199.13%	-49.61%	-30.19%
Return on Assets (ROA)	-91.31%	-82.94%	-104.55%	-92.88%	-30.09%	-18.05%
Return on Capital Employed (ROCE)	-172.00%	-110.90%	-634.80%	-431.40%	-69.20%	-36.20%
Earnings Yield	-77.65%	-95.56%	-82.60%	-385.60%	-28.24%	-9.19%
FCF Yield	-	-51.34%	-104.41%	-183.25%	-29.71%	-9.18%
Buyback Yield / Dilution	-243.45%	-316.79%	-112.20%	-72.02%	-	-6.05%